Guoyu Huang

Chief Financial Officer at Biomark Diagnostics.

Raised on Biomark Diagnostics filings

$2.5M

of $2.5M offered across 1 Form D filing

Company

Biotech

Blood tests for early lung, breast and pancreatic cancer

Blood tests for early lung, breast and pancreatic cancer

Biomark Diagnostics Form D filings
Filed	Security	Sold of offered	Filing
Apr 14, 2025	Equity	$2.5M/ $2.5M	Form D